Literature DB >> 3167025

One free sulfhydryl group of plasma fibronectin becomes titratable upon binding of the protein to solid substrates.

C Narasimhan1, C S Lai, A Haas, J McCarthy.   

Abstract

The accessibility in human plasma fibronectin of the two free sulfhydryl groups per chain to sulfhydryl reagents 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) and a maleimide derivative has been examined. For soluble fibronectin, the free sulfhydryl groups are not accessible to DTNB unless urea or guanidine hydrochloride is added [Smith et al. (1982) J. Biol. Chem. 257, 5831-5838]. Upon binding to polystyrene beads, 0.87 +/- 0.05 sulfhydryl group per chain becomes titratable to DTNB. Experiments using fibronectin fragments demonstrate that this newly exposed sulfhydryl group is located in a Type III homologous unit between the DNA-binding and the cell-binding domains. The results suggest that, upon adsorption to solid substrates, plasma fibronectin undergoes a conformational change, thereby exposing one buried sulfhydryl group. These findings have implications regarding the "surface activation" of adhesion activities of fibronectin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3167025     DOI: 10.1021/bi00414a003

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  3 in total

1.  Evidence that the two free sulfhydryl groups of plasma fibronectin are in different local environments. Saturation-recovery electron spin resonance study.

Authors:  C S Lai; C Narasimhan; J J Yin
Journal:  Biophys J       Date:  1989-08       Impact factor: 4.033

2.  Effect of receptor-ligand affinity on the strength of endothelial cell adhesion.

Authors:  Y Xiao; G A Truskey
Journal:  Biophys J       Date:  1996-11       Impact factor: 4.033

3.  Functional heterogeneity of type 1 fimbriae of Escherichia coli.

Authors:  E V Sokurenko; H S Courtney; S N Abraham; P Klemm; D L Hasty
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.